Free Trial

Cameco (NYSE:CCJ) Upgraded at Stifel Canada

Cameco logo with Basic Materials background
Remove Ads

Stifel Canada upgraded shares of Cameco (NYSE:CCJ - Free Report) TSE: CCO to a strong-buy rating in a report published on Wednesday, March 12th,Zacks.com reports.

Other analysts have also issued reports about the stock. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $90.00 price objective on shares of Cameco in a research note on Tuesday, March 4th. StockNews.com lowered shares of Cameco from a "hold" rating to a "sell" rating in a research note on Tuesday, March 11th. Stifel Nicolaus assumed coverage on shares of Cameco in a research report on Wednesday, March 12th. They set a "buy" rating for the company. Finally, Glj Research increased their price target on shares of Cameco from $62.76 to $75.68 and gave the company a "buy" rating in a research report on Wednesday, March 12th. One research analyst has rated the stock with a hold rating, seven have issued a buy rating and three have given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $73.64.

Check Out Our Latest Research Report on CCJ

Remove Ads

Cameco Trading Up 2.5 %

Shares of NYSE CCJ traded up $1.08 during mid-day trading on Wednesday, reaching $44.17. The company had a trading volume of 3,028,670 shares, compared to its average volume of 4,082,445. Cameco has a 52 week low of $35.43 and a 52 week high of $62.55. The business's 50-day moving average is $47.40 and its 200-day moving average is $50.07. The stock has a market cap of $19.23 billion, a price-to-earnings ratio of 157.74 and a beta of 1.04. The company has a current ratio of 2.88, a quick ratio of 1.26 and a debt-to-equity ratio of 0.20.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last released its quarterly earnings data on Thursday, February 20th. The basic materials company reported $0.26 earnings per share for the quarter, hitting analysts' consensus estimates of $0.26. Cameco had a net margin of 5.39% and a return on equity of 4.34%. The company had revenue of $845.54 million during the quarter, compared to analyst estimates of $1.09 billion. Equities analysts expect that Cameco will post 1.27 earnings per share for the current year.

Hedge Funds Weigh In On Cameco

Hedge funds and other institutional investors have recently modified their holdings of the stock. Sierra Ocean LLC purchased a new position in shares of Cameco in the 4th quarter valued at approximately $25,000. Hurley Capital LLC acquired a new position in Cameco in the 4th quarter worth approximately $27,000. Bank Julius Baer & Co. Ltd Zurich acquired a new position in Cameco in the 4th quarter worth approximately $28,000. Pingora Partners LLC acquired a new position in Cameco in the 3rd quarter worth approximately $33,000. Finally, Whipplewood Advisors LLC acquired a new position in Cameco in the 4th quarter worth approximately $33,000. 70.21% of the stock is owned by hedge funds and other institutional investors.

About Cameco

(Get Free Report)

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.

Recommended Stories

Analyst Recommendations for Cameco (NYSE:CCJ)

Should You Invest $1,000 in Cameco Right Now?

Before you consider Cameco, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.

While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

The Future of Healthcare: 3 AI Stocks Leading the Way

The Future of Healthcare: 3 AI Stocks Leading the Way

2025 promises explosive growth for AI, but which companies are making a difference in healthcare? Chris Markoch highlights three stocks leading the charge.

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads